Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer

Anxiety Clinical Trial

Official title:

Effects of Aromatherapy on Sleep Quality and Anxiety in Patients Undergoing Chemotherapy for Breast Cancer

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06338527
• Other study ID #: 2024YX321
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 26, 2024
• Est. completion date: June 15, 2024

Study information

• Verified date: March 2024
• Source: Weifang Medical University
• Contact: Jiang Liu, Researcher
• Phone: +8617667192336
• Email: Time1987fx[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this study was to investigate the effects of aromatherapy on sleep quality and anxiety in patients undergoing chemotherapy for breast cancer.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 90
• Est. completion date: June 15, 2024
• Est. primary completion date: June 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria: 1) patients diagnosed with breast cancer and receiving chemotherapy; 2) suffering from sleep disorders or PSQI score greater than 5; 3) not using medications such as antidepressants and hypnotics that may affect the observation results; 4) age older than 18 years and volunteered to participate in this study. Exclusion Criteria: 1) Asthma or severe respiratory disease; 2) Allergy to lavender; 3) Cognitive or communication disorders; 4) Breast cancer combined with severe organ dysfunction.

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Sleep Quality

Intervention

Other:
• Aromatherapy
Lavender oil was used for aromatherapy intervention.
• No intervention
No aromatherapy intervention was performed during the period of the study.

Locations

Country	Name	City	State
China	Weifang People's Hospital	Weifang	Shangdong

Sponsors (1)

Lead Sponsor	Collaborator
Weifang Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sleep quality	The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleeping quality of the patients. The total score of PSQI ranged from 0-21, with higher scores indicating poor sleep quality.	The sleep quality of the patients was assessed at 8 a.m. for one week.
Primary	Anxiety	Beck Anxiety Inventory (BAI) was used to assess the anxiety level of the patients. The scale consists of 21 entries with a total score ranging from 0 to 63, with higher total scores being associated with more severe levels of anxiety.	The anxiety level of the patients was assessed at 8 a.m. for one week.